Transaction · 0001961994-26-000029

Williams Paul Anthony

Williams Paul Anthony, SVP, PB, reported an open-market or private sale at Emergent BioSolutions Inc. involving 3000.000000 shares for an estimated $19590.00. Reported holdings after the transaction were 156098.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSVP, PB
EBSEmergent BioSolutions Inc.
Filing timeOct 05
Trade dateOct 01, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded1.89%Shares sold ÷ (holdings after + shares sold). Estimated position before: 159,098 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$5.40
Pre-filing
1mo ago +0.0%1w ago +0.0%1d ago +0.0%
Returns since
7d30d90d180d1y

EBS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
EBS since 2026-10-05Filed today · pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001961994-26-000029
Common Stock
Transaction date
Oct 01, 2026
Filed Oct 05, 2026, 01:16 PM · 4d delay
Shares
3.00k sh
$6.53 per share
Estimated value
-$19.5k
Computed from shares × price
Holdings after
156k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

SVP, Products Business

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 14, 2025 that is intended to comply with Rule 10b5-1(c) under the Securities Exc…

  2. F2

    The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $6…

Original filing · 0001961994-26-000029
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

EBS